Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
EPS (Diluted)
Talis Biomedical Corp
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
EPS (Diluted)
-$34
|
CAGR 3-Years
16%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Talis Biomedical Corp's EPS (Diluted)?
EPS (Diluted)
-34.1
USD
Based on the financial report for Dec 31, 2023, Talis Biomedical Corp's EPS (Diluted) amounts to -34.1 USD.
What is Talis Biomedical Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-20%
Over the last year, the EPS (Diluted) growth was 46%. The average annual EPS (Diluted) growth rates for Talis Biomedical Corp have been 16% over the past three years , -20% over the past five years .